Johannes Oosthuizen - Feb 8, 2025 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
President, U.S. Market
Signature
/s/ Kelly E. W. Grez, as attorney-in-fact for Johannes Oosthuizen
Stock symbol
MRK
Transactions as of
Feb 8, 2025
Transactions value $
$575,873
Form type
4
Date filed
2/11/2025, 02:59 PM
Previous filing
Jan 29, 2025
Next filing
Feb 20, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Options Exercise $1.13M +13K +39.87% $87.28 45.6K Feb 8, 2025 Direct
transaction MRK Common Stock Tax liability -$559K -6.4K -14.04% $87.28 39.2K Feb 8, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Restricted Stock Unit Options Exercise $0 -13K -100% $0.00 0 Feb 8, 2025 Common Stock 13K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F2 These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in one installment on 2/8/2025. The Reporting Person's Form 3 filed on 3/10/2022 incorrectly reported that these restricted units vested and were to be distributed in three equal installments on 2/8/2023, 2/8/2024, and 2/8/2025.